‘Blood on your hands’ if world steps back on tackling COVID now – WHO official

‘Blood on your hands’ if world steps back on tackling COVID now – WHO official

‘Blood on your hands’ if world steps back on tackling COVID now – WHO official By Reuters

Breaking News

‘;

Stock Markets 9 minutes ago (Sep 23, 2022 11:01AM ET)

(C) Reuters. FILE PHOTO: Bruce Aylward, Senior Advisor to the Director-General of the World Health Organization (WHO), speaks during a news conference in Geneva, Switzerland, December 20, 2021. REUTERS/Denis Balibouse

By Jennifer Rigby

LONDON (Reuters) -If rich nations think the pandemic is over, they should help lower-income countries reach that point too, a senior World Health Organization official told Reuters.

In an interview, WHO senior adviser Bruce Aylward warned that richer nations must not step back from tackling COVID-19 as a global problem now, ahead of future potential waves of infection.

In the last few weeks, WHO Director General Tedros Adhanom Ghebreyesus said the end of the pandemic was in sight, and U.S President Joe Biden said the pandemic was over.

“When I hear them say, ‘Well, we’re so comfortable here,’ it’s like, ‘Great, now you can really help us get the rest of the world done’,” said Aylward.

Aylward said that the group he co-ordinates, which focuses on equitable access to COVID-19 vaccines, treatments and tests worldwide, is not yet ready to move out of the emergency phase of tackling the pandemic and that countries need to be ready and have treatments in place for any further waves of infection.

“If you go to sleep right now and this wave hits us in three months… God – blood on your hands,” he said.

He also stressed that Biden had a point domestically as the United States has good access to all COVID tools. It has also not cut its global commitment to fighting COVID, he added.

Aylward co-ordinates the ACT-Accelerator, a partnership between WHO and other global health bodies to help poorer countries access COVID-19 tools. The effort, which includes the vaccine-focused COVAX, has reached billions of people worldwide but has faced criticism for not acting quickly enough. There had been some speculation that the effort may wind up this autumn, but Aylward said it was simply changing its focus as the pandemic changes.

Over the next six months, the partnership will aim particularly at delivering vaccines to the roughly one quarter of the world’s health care workers and elderly who have still not had a shot, as well as on improving access to test-and-treat, particularly with Pfizer (NYSE:PFE)’s Paxlovid, he said.

It will also look to the future as COVID is “here to stay”, and unless systems are put in place, support will collapse once other industrialised nations also think the pandemic is over, said Aylward.

The initiative already has an $11 billion gap in its budget, with most of its available $5.7 billion in funding pledged towards vaccines rather than tests or treatments.

‘Blood on your hands’ if world steps back on tackling COVID now – WHO official

Exclusive-Blackstone to sell $400 million stake in Indian REIT Embassy; ADIA eyes investment-sourcesBy Reuters – Sep 23, 2022

By M. Sriram, Aditya Kalra and Aditi Shah MUMBAI (Reuters) – Blackstone (NYSE:BX) Inc will sell a stake worth up to $400 million in Embassy Office Parks REIT, India’s biggest real…

Alphabet CEO Says Employees ‘Shouldn’t Always Equate Fun with Money’ – CNBCBy Investing.com – Sep 23, 2022

By Sam Boughedda
According to a report by CNBC Friday, CEO Sundar Pichai of Google parent company Alphabet (NASDAQ:GOOGL) faced questions from employees at an all-hands meeting…

Union seeks representation election for 3,000 JetBlue ground workersBy Reuters – Sep 23, 2022

WASHINGTON (Reuters) – The International Association of Machinists and Aerospace Workers (IAM) said Friday it is filing an application seeking an election to represent about…

Our Apps



Terms And Conditions
Privacy Policy
Risk Warning

(C) 2007-2022 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.